Antonia M. Joussen

Department of ophthalmology University of Heidelberg, Heidelberg, Baden-Württemberg, Germany 
 Department of ophthalmology Rheinisch-Westfaelische Technische Hochschule, Aachen, NRW, Germany 
 Department of ophthalmology University of Cologne, Köln, Nordrhein-Westfalen, Germany 
 1999-2001 Children's Hospital and Harvard Medical School, Boston, MA, United States 
 2000-2000 Massachusetts Eye and Ear Infirmary, Boston, MA, United States 
 2006-2009 Department of ophthalmology Heinrich Heine University Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany 
 2010- Department of ophthalmology Charité Hospital, Berlin, Berlin, Berlin, Germany 
"Antonia Joussen"

Professor Dr. Antonia M. Joussen is a vitreoretinal surgeon. She holds a Chair position in ophthalmology at the Charité – University Medicine Berlin in Germany at two campuses, Campus Virchow-Klinikum and Campus Benjamin Franklin.

After attending medical school in Heidelberg, Vienna and London, she received her PhD from the University of Heidelberg in 1996. During her ophthalmology residency at the University of Heidelberg and RWTH Aachen University, Germany, she performed a research fellowship at the Boston Children’s Hospital in Massachusetts, USA. In 2000, she was appointed as an instructor at Massachusetts Eye and Ear, Harvard Medical School. After returning to Germany, she received the Emmy Noether Career Development Grant (Scientific Excellence Program) from the German Research Foundation from 2002 to 2007.

(Show more)

Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Riechardt AI, Kilic E, Joussen AM. (2021) The Genetics of Uveal Melanoma: Overview and Clinical Relevance. Klinische Monatsblatter Fur Augenheilkunde. 238: 773-780
Bechrakis NE, Bornfeld N, Heindl LM, et al. (2021) Uveal Melanoma - Standardised Procedure in Diagnosis, Therapy and Surveillance. Klinische Monatsblatter Fur Augenheilkunde. 238: 761-772
Rübsam A, Wernecke L, Rau S, et al. (2021) Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants. Journal of Diabetes Research. 2021: 8820216
Crespo-Garcia S, Reichhart N, Kociok N, et al. (2021) Anti-Inflammatory Role of Netrin-4 in Diabetic Retinopathy. International Journal of Molecular Sciences. 22
Maier AB, Reichhart N, Gonnermann J, et al. (2021) Effects of TNFα receptor TNF-Rp55- or TNF-Rp75- deficiency on corneal neovascularization and lymphangiogenesis in the mouse. Plos One. 16: e0245143
Uemura A, Fruttiger M, D'Amore PA, et al. (2021) VEGFR1 signaling in retinal angiogenesis and microinflammation. Progress in Retinal and Eye Research. 100954
Gundlach E, Pilger D, Brockmann T, et al. (2021) Recovery of Contrast Sensitivity After Descemet Membrane Endothelial Keratoplasty. Cornea
Joussen AM, Ricci F, Paris LP, et al. (2021) Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data. Eye (London, England)
Korobelnik JF, Loewenstein A, Eldem B, et al. (2021) Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
Tsang JKW, Wolf SA, Pompoes IM, et al. (2021) Potential Effects of Nutraceuticals in Retinopathy of Prematurity. Life (Basel, Switzerland). 11
See more...